# Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

> **NCT06252493** · — · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Radiotracer Injection
- **DRUG:** Contrast Media, Magnetic Resonance
- **DIAGNOSTIC_TEST:** Blood Draw
- **DRUG:** Glucagon
- **DIAGNOSTIC_TEST:** Imaging
- **DRUG:** Oral contrast media application

## Key facts

- **NCT ID:** NCT06252493
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-19
- **Primary completion:** 2027-12-19
- **Final completion:** 2029-12-19
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06252493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06252493, "Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT06252493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*